• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

26.07 +0.07 (+0.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amphastar Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving
January 15, 2026
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 5.3% in the afternoon session after a Bank of America analyst lowered the firm's price target on the shares and reports... 
Via StockStory
News headline image
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead
January 14, 2026
Amphastar Pharmaceuticals has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.5%. The stock now trades at $27.76, marking a 31% gain. This was partly due to... 
Via StockStory
Topics Stocks Supply Chain
News headline image
1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
January 13, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
 
Via Benzinga
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
January 12, 2026
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 5.8% in the afternoon session after the company announced it had entered into an exclusive license agreement with Nanjing... 
Via StockStory
News headline image
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
January 12, 2026
Via ACCESS Newswire
News headline image
3 Low-Volatility Stocks We Find Risky
January 07, 2026
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
January 07, 2026
Via ACCESS Newswire
News headline image
Amphastar Director Sells 16,679 Shares for $441,800 ↗
December 23, 2025
Amphastar is down big in 2025, but recently announced positive FDA-related news. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Healthcare Stocks with Questionable Fundamentals
December 15, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have... 
Via StockStory
Topics Stocks
News headline image
Amphastar Announces FDA Approval for Teriparatide Injection
December 15, 2025
Via ACCESS Newswire
News headline image
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges
December 11, 2025
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these... 
Via StockStory
News headline image
1 Stock Under $50 Worth Your Attention and 2 We Brush Off
December 08, 2025
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
News headline image
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why
December 03, 2025
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 3.7% in the afternoon session after positive analyst sentiment and technical trading indicators pointed to potential... 
Via StockStory
Topics Economy
News headline image
Amphastar (AMPH) Q3 2025 Earnings Call Transcript ↗
November 27, 2025
Amphastar (AMPH) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
November 24, 2025
Via ACCESS Newswire
News headline image
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
November 21, 2025
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Unpacking Q3 Earnings: Amneal (NASDAQ:AMRX) In The Context Of Other Generic Pharmaceuticals Stocks
November 19, 2025
Looking back on generic pharmaceuticals stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Amneal (NASDAQ:AMRX) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Small-Cap Stocks with Questionable Fundamentals
November 17, 2025
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
5 Must-Read Analyst Questions From Amphastar Pharmaceuticals’s Q3 Earnings Call
November 13, 2025
Amphastar Pharmaceuticals' third quarter results for 2025 came in ahead of Wall Street's revenue and profit expectations, despite essentially flat sales compared to the prior year. The quarter was... 
Via StockStory
Topics Earnings
News headline image
Reflecting On Generic Pharmaceuticals Stocks’ Q3 Earnings: Viatris (NASDAQ:VTRS)
November 12, 2025
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Viatris (NASDAQ:VTRS) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
November 12, 2025
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 3.9% in the afternoon session after the stock's positive momentum continued as the company reported impressive financial... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
November 12, 2025
Via ACCESS Newswire
News headline image
Generic Pharmaceuticals Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Simply the Best
November 11, 2025
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Why Are Amphastar Pharmaceuticals (AMPH) Shares Soaring Today
November 10, 2025
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 10.9% in the afternoon session after the stock's positive momentum continued as the company reported third-quarter... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
AMPH Q3 Deep Dive: Pipeline Expansion and Core Product Growth Offset Margin Pressures
November 10, 2025
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported Q3 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $191.8 million. Its non-GAAP... 
Via StockStory
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Up Today
November 07, 2025
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 4.9% in the afternoon session after the company reported third-quarter 2025 financial results that surpassed analyst... 
Via StockStory
Topics Artificial Intelligence Economy Government
News headline image
The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts ↗
November 07, 2025
 
Via Benzinga
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Delivers Strong Q3 Numbers
November 06, 2025
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales were flat year on year at $191.8 million. Its non-GAAP profit... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
November 06, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap